The altered TrkB expression, signaling and mutations have been proved to play an essential role in regulating oncogenesis and tumor progression in various cancers, including carcinomas of the pancreas, lung, colon and prostate, neuroblastoma and multiple myeloma [12]. The gene discussed is NTRK2; the disease is plasma cell myeloma.